Outcomes of adult patients in the intensive care unit with Pseudomonas aeruginosa pneumonia who received an active anti‐pseudomonal β‐lactam: Does “S” equal success in the presence of resistance to other anti‐pseudomonal β‐lactams?-Reference-Cited by-同舟云学术

Outcomes of adult patients in the intensive care unit with Pseudomonas aeruginosa pneumonia who received an active anti‐pseudomonal β‐lactam: Does “S” equal success in the presence of resistance to other anti‐pseudomonal β‐lactams?

Published:2021-07-05 Issue:8 Volume:41 Page:658-667
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Lodise Thomas P.¹^ORCID,Puzniak Laura A.²,Chen Lie H.³,Tian Yun³,Wei Rong³,Im Theresa M.³,Tartof Sara Y.³

Affiliation:

1. Abany College of Pharmacy Health Sciences Albany New York USA

2. Merck & Co., Inc. Kenilworth New Jersey USA

3. Kaiser Permanente Southern California Department of Research & Evaluation Pasadena California USA

Funder

Merck

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2600

Reference29 articles.

1. Emerging infections program healthcare‐associated I, antimicrobial use prevalence survey T. Survey of health care‐associated infections;Magill SS;N Engl J Med,2014

2. Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014

3. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society

4. Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party†

5. Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: guidelines by the Spanish Society of Chemotherapy;Mensa J;Rev Esp Quimioter,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative evaluation of early treatment with ceftolozane/tazobactam versus ceftazidime/avibactam for non-COVID-19 patients with pneumonia due to multidrug-resistant Pseudomonas aeruginosa;Journal of Antimicrobial Chemotherapy;2024-09-11

2. Perspectives on the use of ceftolozane/tazobactam: a review of clinical trial data and real-world evidence;Future Microbiology;2024-01-22

3. Participant- and Disease-Related Factors as Independent Predictors of Treatment Outcomes in the RESTORE-IMI 2 Clinical Trial: A Multivariable Regression Analysis;Open Forum Infectious Diseases;2023-05-04